Percheron Therapeutics Management
Management criteria checks 2/4
Percheron Therapeutics' CEO is James Garner, appointed in Aug 2023, has a tenure of less than a year. directly owns 0.11% of the company’s shares, worth A$73.00K. The average tenure of the management team and the board of directors is 2.3 years and 2.6 years respectively.
Key information
James Garner
Chief executive officer
AU$33.8k
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.1% |
Management average tenure | 2.3yrs |
Board average tenure | 2.6yrs |
Recent management updates
Recent updates
We Think Antisense Therapeutics (ASX:ANP) Needs To Drive Business Growth Carefully
Nov 13We're Not Very Worried About Antisense Therapeutics' (ASX:ANP) Cash Burn Rate
Jun 08We Think Antisense Therapeutics (ASX:ANP) Can Afford To Drive Business Growth
Feb 14We're Hopeful That Antisense Therapeutics (ASX:ANP) Will Use Its Cash Wisely
Aug 26Here's Why We're Not Too Worried About Antisense Therapeutics' (ASX:ANP) Cash Burn Situation
May 12We Think Antisense Therapeutics (ASX:ANP) Needs To Drive Business Growth Carefully
Dec 23Here's Why We're Not Too Worried About Antisense Therapeutics' (ASX:ANP) Cash Burn Situation
Jun 24We Think Antisense Therapeutics (ASX:ANP) Can Afford To Drive Business Growth
Mar 11Will Antisense Therapeutics (ASX:ANP) Spend Its Cash Wisely?
Nov 26CEO
James Garner (50 yo)
less than a year
Tenure
AU$33,804
Compensation
Dr. James Garner, MA, MBA, MBBS, BSC (Hons), MAICD, serves as Non-Executive Director at Percheron Therapeutics Limited (formerly known as Antisense Therapeutics Limited) since May 08, 2023 and has been its...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD & Director | less than a year | AU$33.80k | 0.11% A$ 73.0k | |
Chief Operating Officer | 1.3yrs | AU$463.17k | no data | |
CFO & Joint Company Secretary | 17.5yrs | no data | 0.84% A$ 555.7k | |
Joint Company Secretary | 3.3yrs | no data | no data |
2.3yrs
Average Tenure
Experienced Management: PER's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD & Director | less than a year | AU$33.80k | 0.11% A$ 73.0k | |
Independent Non-Executive Director | 2.6yrs | AU$92.02k | 0.11% A$ 73.0k | |
Independent Non-Executive Chair | 3.2yrs | AU$159.26k | 0.081% A$ 53.5k |
2.6yrs
Average Tenure
Experienced Board: PER's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.